Skip to main content
. Author manuscript; available in PMC: 2013 Nov 4.
Published in final edited form as: Cancer Epidemiol. 2009 Nov 20;33(6):10.1016/j.canep.2009.10.013. doi: 10.1016/j.canep.2009.10.013

Table 4.

Results of testing for human papillomavirus (HPV) by PCR, Hybrid Capture 2 (HC2) and Pap smear relative to histology (40 women with high-grade lesiona, 26 with low-grade lesionb and 446 women with no lesionc).

Specimen Type of lesion
Test index % (95% CI) for HSIL
High-grade Low-grade Otherc Total Sensitivity Specificity PPV NPV DA
PCR-P 35 9 23 67 87.5 (77.2, 97.8) 93.2 (91.0, 95.5) 52.2 (40.3, 64.2) 98.9 (97.9, 99.9) 92.8 (90.6, 95.0)
PCR-S 33 8 22 63 82.5 (70.7, 94.3) 93.6 (91.5, 95.9) 52.4 (40.0, 64.7) 98.4 (97.3, 99.6) 92.8 (90.6, 95.0)
HC2-P 36 8 31 75 90.0 (80.7, 99.3) 91.7 (89.3, 94.2) 48.0 (36.7, 59.3) 99.1 (98.2, 100.0) 91.6 (89.2, 94.0)
HC2-S 32 7 49 88 80.0 (67.6, 92.4) 88.1 (85.3, 91.1) 36.4 (26.3, 46.4) 98.1 (96.8, 99.4) 87.5 (84.7, 90.4)
Pap≥ASCUS 31 8 52 91 77.5 (61.1, 88.6) 87.3 (83.9, 90.1) 34.1 (24.7, 44.8) 97.9 (95.8, 99.0) 86.5 (83.5, 89.5)
Pap≥LSIL 28 4 21 53 70.0 (53.3, 82.9) 94.7 (92.2, 96.5) 52.8 (32.8, 66.5) 97.4 (95.4, 98.6) 92.8 (90.6, 95.0)

PPV: positive predictive value; NPV: negative predictive value; DA: diagnostic accuracy (true positive + true negative/total no. of cases); PCR-P: physician-collected sample tested by PCR; PCR-S: self-collected sample tested by PCR.

a

Women with high-grade lesion equivalent to CIN2, 3 or Ca was diagnosed by cervical biopsy.

b

Women with low-grade lesion equivalent to CIN1 was diagnosed by cervical biopsy.

c

Women with cervical biopsy indicated no SIL and women with normal cervix on colposcopy.